1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
159.06 0.47 (0.30%)
909.0K
XNAS Volume

XNAS 06 Aug, 2026 3:54 PM (EDT)

Watchlist

Portfolio

Alert

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 22 analysts

Repligen Corp has a share price target of US$ 186, revenue growth forecast of 12.0%, and profit growth estimate of -14.3% for FY26, based on top 22 analyst calls.